CD8A and neoplasm: There was a 4-fold increase in the CD8+ T cell to Treg cell ratio in the tumor after PD-1–laIL-2 treatment (Figure 4F), suggesting that PD-1–laIL-2 promotes an immune-active environment in the tumor.